A literature review on the efficacy and safety of botulinum toxin: an injection in post-stroke spasticity

Majid Ghasemi, Mehri Salari, Fariborz Khorvash, Vahid Shaygannejad, Majid Ghasemi, Mehri Salari, Fariborz Khorvash, Vahid Shaygannejad

Abstract

Background: A variety of techniques for the management of spasticity have been suggested, including positioning, cryotherapy, splinting and casting, biofeedback, electrical stimulation, and medical management by pharmacological agents, Botulinum toxin A (BTA) is now the pharmacological treatment of choice in focal spasticity. BTA by blocking acetylcholine release at neuromuscular junctions accounts for its therapeutic action to relieve spasticity.

Methods: A computerized search of Pub Med was carried out to find the latest result about efficacy of BTA in management of post stroke spasticity.

Result: Among 84 articles were found, frothy of them included in this review and divided to lower and upper extremity.

Conclusions: BTA is a treatment choice in reducing tone and managing post stroke spasticity .

Keywords: Botulinum toxin A; spasticity; stroke.

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Mechanism of action of botulinum toxin A

References

    1. Sommerfeld DK, Gripenstedt U, Welmer AK. Spasticity after stroke an overview of prevalence, test instruments, and treatments. Am J Phys Med Rehabil. 2012;91:814–20.
    1. Nabavi SM, Jafari B, Jalali MS, Nedjat S, Ashrafi K, Salahesh A. Environmental air pollution and acute cerebrovascular complications: An ecologic study in Tehran, Iran. Int J Prev Med. 2012;3:723–9.
    1. Zare M, Saadatnia M. The effect of statin therapy in stroke outcome: A double blind clinical trial. Int J Prev Med. 2012;3:68–72.
    1. Borg J, Ward AB, Wissel J. Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: Evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity. J Rehabil Med. 2011;43:15–22.
    1. Sommerfeld DK, Eek EU, Svensson AK. Spasticity after stroke: Its occurrence and association with motor impairments and activity limitations. Stroke. 2004;35:134–9.
    1. Ward AB. A literature review of the pathophysiology and onset of post-stroke spasticity. Eur J Neurol. 2012;19:21–7.
    1. Gallichio JE. Pharmacologic management of spasticity following stroke. Phys Ther. 2004;84:973–81.
    1. Ozcakir S, Sivrioglu K. Botulinum toxin in poststroke spasticity. Clin Med Res. 2007;5:132–8.
    1. Dhaked RK, Singh MK, Singh P, Gupta P. Botulinum toxin: bioweapon and magic drug. Indian J Med Res. 2010;132:489–503.
    1. Dolly O. Synaptic transmission: Inhibition of neurotransmitter release by botulinum toxins. Headache. 2003;43:S16–24.
    1. Raciborska DA, Charlton MP. Retention of cleaved synaptosome-associated protein of 25 kDa (SNAP-25) in neuromuscular junctions: A new hypothesis to explain persistence of botulinum A poisoning. Can J Physiol Pharmacol. 1999;77:679–88.
    1. Keller JE, Neale EA, Oyler G, Adler M. Persistence of botulinum neurotoxin action in cultured spinal cord cells. FEBS Lett. 1999;456:137–42.
    1. De Paiva A, Meunier FA, Molgó J, Aoki KR, Dolly JO. Functional repair of motor endplates after botulinum neurotoxin type A poisoning: Biphasic switch of synaptic activity between nerve sprouts and their parent terminals. Proc Natl Acad Sci U S A. 1999;96:3200–5.
    1. Dobkin BH, Landau WM, Sahrmann S, Thomas Thach W, Simpson DM, Gracies JM, et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review) Neurology. 2009;73:736.
    1. Pittock SJ, Moore AP, Hardiman O, Ehler E, Kovac M, Bojakowski J, et al. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis. 2003;15:289–300.
    1. Yelnik AP, Bonan IV. Poststroke hemiplegia: Lower limb benefit from botulinum toxin (review) Ann Readapt Med Phys. 2003;46:281–5.
    1. Foley N, Murie-Fernandez M, Speechley M, Salter K, Sequeira K, Teasell R. Does the treatment of spastic equinovarus deformity following stroke with botulinum toxin increase gait velocity? A systematic review and meta-analysis. Eur J Neurol. 2010;17:1419–27.
    1. Dunne JW, Gracies JM, Hayes M, Zeman B, Singer BJ Multicentre Study Group. A prospective, multicentre, randomized, double-blind, placebo-controlled trial of onabotulinumtoxin A to treat plantarflexor/invertor overactivity after stroke. Clin Rehabil. 2012;26:787–97.
    1. McIntyre A, Lee T, Janzen S, Mays R, Mehta S, Teasell R. Systematic review of the effectiveness of pharmacological interventions in the treatment of spasticity of the hemiparetic lower extremity more than six months post stroke. Top Stroke Rehabil. 2012;19:479–90.
    1. Girlanda P, Quartarone A, Sinicropi S. Botulinum toxin in upper limb spasticity: Study of reciprocal inhibition between forearm muscles. Neuroreport. 1997;8:3039–44.
    1. Lagalla G, Danni M, Reiter F, Ceravolo MG, Provinciali L. Post-stroke spasticity management with repeated botulinum toxin injections in the upper limb. Am J Phys Med Rehabil. 2000;79:377–84.
    1. Bakheit AM, Pittock S, Moore AP, Wurker M, Otto S, Erbguth F, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol. 2001;8:559–6.
    1. Brashear A, Gordon MF, Elovic E, Kassicieh VD, Marciniak C, Do M, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med. 2002;374:395–400.
    1. van Kuijk AA, Geurts AC, Bevaart BJ, van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: A systematic review of the literature. J Rehabil Med. 2002;34:51–61.
    1. Rousseaux M, Launay MJ, Kozlowski O. Poststroke hemiplegia: Interest of botulinum toxin injection at the upper limb. Ann Readapt Med Phys. 2003;46:286–95.
    1. Yelnik AP. Pharmacology and upper limb poststroke spasticity: A review International Society of Prosthetics and Orthotics. Ann Readapt Med Phys. 2004;47:575–89.
    1. Miscio G, Del Conte C, Pianca D. Botulinum toxin in post-stroke patients: Stiffness modifications and clinical implications. J Neurol. 2004;251:189–96.
    1. Cardoso E, Rodrigues B, Lucena R, Oliveira IR, Pedreira G, Melo A. Botulinum toxin type A for the treatment of the upper limb spasticity after stroke: A meta-analysis. Arq Neuropsiquiatr. 2005;63:30–3.
    1. Slawek J, Bogucki A, Reclawowicz D. Botulinum toxin type A for upper limb spasticity following stroke: An open-label study with individualised, flexible injection regimens. Neurol Sci. 2005;26:32–9.
    1. Jahangir AW, Tan HJ, Norlinah MI. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke. Med J Malaysia. 2007;62:319–22.
    1. Bhakta BB, O’Connor RJ, Cozens JA. Associated reactions after stroke: A randomized controlled trial of the effect of botulinum toxin type A. J Rehabil Med. 2008;40:36–41.
    1. Trompetto C, Bove M, Avanzino L. Intrafusal effects of botulinum toxin in post-stroke upper limb spasticity. Eur J Neurol. 2008;15:367–70.
    1. McCrory P, Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Sandanam J, et al. Botulinum toxin A for treatment of upper limb spasticity following stroke: A multi-centre randomized placebo-controlled study of the effects on quality of life and other person-centred outcomes. J Rehabil Med. 2009;41:536–44.
    1. Ashford S, Turner-Stokes L. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: A preliminary analysis of goals and outcomes. Disabil Rehabil. 2009;31:220–6.
    1. Senkárová Z, Hlustík P, Otruba P, Herzig R, KanovskÝ P. Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: An fMRI study. J Neuroimaging. 2010;20:9–15.
    1. Turner-Stokes L, Baguley IJ, De Graaff S, Katrak P, Davies L, McCrory P, et al. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: A secondary analysis from a doubleblind placebo-controlled randomized clinical trial. J Rehabil Med. 2010;42:81–9.
    1. Kaňovský P, Slawek J, Denes Z, Platz T, Comes G, Grafe S, et al. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity. J Rehabil Med. 2011;43:486–92.
    1. Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M, et al. Botulinum toxin type A in post-stroke upper limb spasticity. Curr Med Res Opin. 2010;26:1983–92.
    1. Cousins E, Ward A, Roffe C. Does low-dose botulinum toxin help the recovery of arm function when given early after stroke? A phase II randomized controlled pilot study to estimate effect size. Clin Rehabil. 2010;24:501–13.
    1. Baguley IJ, Nott MT, Turner-Stokes L, De Graaff S, Katrak P, McCrory P, et al. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity. J Rehabil Med. 2011;43:1032–7.
    1. Tomášová Z, Hluštík P, Král M, Otruba P, Herzig R, Krobot A, et al. Cortical activation changes in patients suffering from post-stroke arm spasticity and treated with botulinum toxin A. J Neuroimaging. 2011;20:1–8.
    1. Rosales RL, Kanovsky P, Fernandez HH. What's the “catch” in upper-limb post-stroke spasticity: Expanding the role of botulinum toxin applications. Parkinsonism Relat Disord. 2011;17(Suppl 1):S3–10.
    1. Yablon SA, Brin MF, VanDenburgh AM, Zhou J, Garabedian-Ruffalo SM, Abu-Shakra S, et al. Dose response with onabotulinumtoxinA for post-stroke spasticity: A pooled data analysis. Mov Disord. 2011;26:209–15.
    1. Veverka T, Hluštík P, Tomášová Z, Hok P, Otruba P, Král M, et al. BoNT-A related changes of cortical activity in patients suffering from severe hand paralysis with arm spasticity following ischemic stroke. J Neurol Sci. 2012;319:89–9.
    1. Rosales RL, Kong KH, Goh KJ, Kumthornthip W, Mok VC, Delgado-De Los Santos MM, et al. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: A randomized controlled trial. Neurorehabil Neural Repair. 2012;26:812–21.
    1. Viriyavejakul A, Vachalathiti R, Poungvarin N. Botulinum treatment for post-stroke spasticity: Low dose regime. J Med Assoc Thai. 1998;81:413–22.
    1. Wissel J, Müller J, Heinen F, Mall V, Sojer M, Ebersbach G, et al. Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group. Wien Klin Wochenschr. 1999;111:837–42.
    1. Fève A. Spasticity and botulinum toxin in 2003. An update. Neurochirurgie. 2003;49:265–70.
    1. Ward A, Roberts G, Warner J. Cost-effectiveness of botulinum toxin type A in the treatment of post-stroke spasticity. J Rehabil Med. 2005;37:252–7.
    1. Cardoso E, Pedreira G, Prazeres A, Ribeiro N, Melo A. Does botulinum toxin improve the function of the patient with spasticity after stroke? Arq Neuropsiquiatr. 2007;65:592–5.
    1. Rosales RL, Chua-Yap AS. Evidence-based systematic review on the efficacy and safety of botulinum toxin-A therapy in post-stroke spasticity. J Neural Transm. 2008;115:617–23.
    1. Elia AE, Filippini G, Calandrella D, Albanese A. Botulinum neurotoxins for post-stroke spasticity in adults: A systematic review. Mov Disord. 2009;24:801–81.
    1. Teasell R, Foley N, Pereira S, Sequeira K, Miller T. Evidence to practice: Botulinum toxin in the treatment of spasticity post stroke. Top Stroke Rehabil. 2012;19:115–21.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다